Literature DB >> 28600746

Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors.

Michelangelo Auteri1, Maria Grazia Zizzo1,2, Antonella Amato1, Rosa Serio3.   

Abstract

Dopamine (DA) acts as gut motility modulator, via D1- and D2-like receptors, but its effective role is far from being clear. Since alterations of the dopaminergic system could lead to gastrointestinal dysfunctions, a characterization of the enteric dopaminergic system is mandatory. In this study, we investigated the role of DA and D1- and D2-like receptors in the contractility of the circular muscle of mouse distal colon by organ-bath technique. DA caused relaxation in carbachol-precontracted circular muscle strips, sensitive to domperidone, D2-like receptor antagonist, and mimicked by bromocriptine, D2-like receptor agonist. 7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH-23390), D1-like receptor antagonist, neural toxins, L-NAME (nitric oxide (NO) synthase inhibitor), 2'-deoxy-N6-methyl adenosine 3',5'-diphosphate diammonium salt (MRS 2179), purinergic P2Y1 antagonist, or adrenergic antagonists were ineffective. DA also reduced the amplitude of neurally evoked cholinergic contractions. The effect was mimicked by (±)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrobromide (SKF-38393), D1-like receptor agonist and antagonized by SCH-23390, MRS 2179, or L-NAME. Western blotting analysis determined the expression of DA receptor proteins in mouse distal colon. Notably, SCH-23390 per se induced an increase in amplitude of spontaneous and neurally evoked cholinergic contractions, unaffected by neural blockers, L-NAME, MRS 2179, muscarinic, adrenergic, or D2-like receptor antagonists. Indeed, SCH-23390-induced effects were antagonized by an adenylyl cyclase blocker. In conclusion, DA inhibits colonic motility in mice via D2- and D1-like receptors, the latter reducing acetylcholine release from enteric neurons, involving nitrergic and purinergic systems. Whether constitutively active D1-like receptors, linked to adenylyl cyclase pathway, are involved in a tonic inhibitory control of colonic contractility is questioned.

Entities:  

Keywords:  Cholinergic neurotransmission; D1-like receptors; D2-like receptors; Dopamine; Intestinal contractility; Mouse

Mesh:

Substances:

Year:  2017        PMID: 28600746     DOI: 10.1007/s13105-017-0566-0

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  35 in total

1.  The beta3-adrenoceptor-mediated relaxation induced by dopamine in guinea pig taenia caecum.

Authors:  Yurie Akimoto; Takahiro Horinouchi; Yoshio Tanaka; Katsuo Koike
Journal:  J Smooth Muscle Res       Date:  2003-06

Review 2.  Dopamine receptor diversity: molecular and pharmacological perspectives.

Authors:  D S Hartman; O Civelli
Journal:  Prog Drug Res       Date:  1997

3.  Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.

Authors:  G Levandis; B Balestra; F Siani; V Rizzo; C Ghezzi; G Ambrosi; S Cerri; A Bonizzi; R Vicini; M Vairetti; A Ferrigno; O Pastoris; F Blandini
Journal:  Neurogastroenterol Motil       Date:  2015-10-03       Impact factor: 3.598

4.  Dopaminergic modulation of rectosigmoid motility: action of domperidone.

Authors:  J Wiley; C Owyang
Journal:  J Pharmacol Exp Ther       Date:  1987-08       Impact factor: 4.030

5.  Inhibitory effect of dopamine on canine gastric fundus.

Authors:  R A Lefebvre; J L Willems; M G Bogaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

Review 6.  Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.

Authors:  M Tonini; L Cipollina; E Poluzzi; F Crema; G R Corazza; F De Ponti
Journal:  Aliment Pharmacol Ther       Date:  2004-02-15       Impact factor: 8.171

7.  Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation.

Authors:  Z S Li; T D Pham; H Tamir; J J Chen; M D Gershon
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

8.  Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.

Authors:  Zhi Shan Li; Claudia Schmauss; Abigail Cuenca; Elyanne Ratcliffe; Michael D Gershon
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

9.  Dopamine-induced relaxation of the guinea-pig isolated jejunum is not mediated through dopamine receptors.

Authors:  A Lucchelli; C Boselli; E Grana
Journal:  Pharmacol Res       Date:  1990 Jul-Aug       Impact factor: 7.658

10.  Effect of itopride hydrochloride on the ileal and colonic motility in guinea pig in vitro.

Authors:  Hyun Chul Lim; Young Gyun Kim; Jung Hyun Lim; Hee Sun Kim; Hyojin Park
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

View more
  4 in total

1.  Altered gastrointestinal motility in an animal model of Lesch-Nyhan disease.

Authors:  Maria G Zizzo; Monica Frinchi; Domenico Nuzzo; Hyder A Jinnah; Giuseppa Mudò; Daniele F Condorelli; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio; Flavia Mulè; Natale Belluardo; Rosa Serio
Journal:  Auton Neurosci       Date:  2017-12-20       Impact factor: 3.145

2.  Dopamine Transporter Genetic Reduction Induces Morpho-Functional Changes in the Enteric Nervous System.

Authors:  Silvia Cerantola; Valentina Caputi; Gabriella Contarini; Maddalena Mereu; Antonella Bertazzo; Annalisa Bosi; Davide Banfi; Dante Mantini; Cristina Giaroni; Maria Cecilia Giron
Journal:  Biomedicines       Date:  2021-04-24

Review 3.  Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003

4.  Dopamine D2-Subtype Receptors Outside the Blood-Brain Barrier Mediate Enhancement of Mesolimbic Dopamine Release and Conditioned Place Preference by Intravenous Dopamine.

Authors:  J Daniel Obray; Christina A Small; Emily K Baldwin; Eun Young Jang; Jin Gyeom Lee; Chae Ha Yang; Jordan T Yorgason; Scott C Steffensen
Journal:  Front Cell Neurosci       Date:  2022-07-12       Impact factor: 6.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.